BI 3720931 is a first-in-class, inhaled lentiviral vector-based gene therapy that could potentially address unmet needs by inserting a functional copy of the CFTR gene in the DNA of airway epithelial ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...

The randomized NLST had shown that three rounds of annual screening with low-dose CT reduced lung cancer mortality by 20% among current and former smokers as compared with the same number of annual ...

A discovery offers new hope in the battle against pulmonary fibrosis, a debilitating lung condition that progressively makes it harder for patients to breathe. Scientists have pinpointed proteins in ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depend on the ability to deliver tiny particles known as aerosols to the correct location in ...

Purpose. The successful use of inhaled morphine to relieve dyspnea in a patient with end-stage cystic fibrosis (CF) lung disease is described. Dyspnea, the sensation of breathlessness or labored ...

cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life, presumably even in ... Feb. 5, 2025 ...

Renita White, MD, is an obstetrician/gynecologist at Georgia Obstetrics and Gynecology in Atlanta, Georgia. Her areas of expertise include fibroids, irregular vaginal ...

Objective: Conventional fine-needle aspiration biopsy (FNAB) for cystic thyroid nodules (CTNs ... or malignant lesion in 16 cases. The final pathology revealed a benign nodule in 98 cases ...